Business Context and Reporting Period
This Form 8-K Current Report was filed by Rigel Pharmaceuticals, Inc. on February 3, 2026, covering events occurring on February 1, 2026. The filing discloses the appointment of a new director to the Company's Board of Directors.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and director compensation arrangements.
Material Changes
The primary material change reported is the appointment of Michael P. Miller to the Board of Directors, effective February 1, 2026. Mr. Miller will serve on the Compensation Committee and is classified as an independent director. His term expires at the 2027 annual stockholders' meeting.
Guidance, Outlook, and Compensation Details
The filing details the compensatory arrangements for the new director:
- Cash Compensation: A yearly retainer of $50,000 plus an additional $10,000 annual retainer for Compensation Committee service, pro-rated for partial periods.
- Equity Grants: An initial grant of options to purchase 12,000 shares of common stock. Future annual grants include options for 3,000 shares and 2,500 restricted stock units, subject to continued service.
- Other: Mr. Miller has entered into the Company's standard indemnification agreement. No family relationships or undisclosed transactions exist between Mr. Miller and other directors or officers.
The filing contains no forward-looking guidance, risk factors, or discussion of unusual items beyond the standard director appointment.
Investor Verification Checklist
- Verify the independence status of Michael P. Miller as determined by the Board.
- Confirm the terms of the 2018 Equity Incentive Plan regarding non-discretionary grants for non-employee directors.
- Review the total number of shares authorized for issuance under the equity plan to assess dilution impact.
- Check for any subsequent filings regarding the resignation or removal of the director.